Upstream Bio Inc
UPB
NASDAQ
Biotechnology
$7.07
USD
+0.16 (+2.32%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $397.81M
Volume 688.2K
Peer Comparison Table
(1/4) | ||||||
|---|---|---|---|---|---|---|
XFOR | X4 Pharmaceuticals Inc | $404.63M | - | -71.3% | - | |
UPB | Upstream Bio Inc | $397.81M | - | +13.2% | - | |
ENTA | Enanta Pharmaceuticals Inc | $391.45M | - | +0.7% | - | |
FHTX | Foghorn Therapeutics Inc | $385.41M | - | +52.0% | - | |
PALI | Palisade Bio Inc | $368.58M | - | - | - | |
RCKT | Rocket Pharmaceuticals Inc | $368.29M | - | - | - | |
DMAC | DiaMedica Therapeutics Inc | $360.76M | - | - | - | |
CAPR | Capricor Therapeutics Inc | $252.50M | - | - | - |
Top Peer by Growth
Foghorn Therapeutics Inc
+52.0% YoY Revenue
Best 1-Year Return
Palisade Bio Inc
+165.4% Return